期刊文献+

促红细胞生成素对大鼠心肌缺血再灌注损伤的保护作用 被引量:5

Protection of Erythropoietin on Myocardial Ischemia-Reperfusion Injury in Rats
暂未订购
导出
摘要 目的:探讨促红细胞生成素(促红素)预处理对大鼠心肌缺血再灌注损伤的保护作用及其可能机制。方法:40只 SD 大鼠随机分为5组(每组8只):假手术组、模型组、促红素组、锌原卟啉组、促红素+锌原卟啉组,建立大鼠心肌缺血再灌注损伤模型,缺血45 min,再灌注180 min,采用免疫组织化学及逆转录—聚合酶链反应分别测定大鼠心肌组织单核细胞趋化蛋白-1(MCP-1)、血红素氧合酶-1(HO-1)和 mRNA 的表达,电镜观察心肌超微结构的病理学改变。结果:与假手术组比,其余4组缺血再灌注心肌中 MCP-1、HO-1免疫组化平均光密度值和逆转录—聚合酶链反应mRNA 表达增多(P 均<0.01),差异有统计学意义;与模型组比,促红素预处理能明显上调 HO-1 mRNA 表达,并降低缺血再灌注心肌 MCP-1 mRNA 表达(P 均<0.05~0.01),差异有统计学意义,同时改善心肌超微结构的损伤,使用锌原卟啉后,促红素预处理的保护作朋消失(P>0.05);与促红素组比较,锌原卟啉组和促红素+锌原卟啉组大鼠心肌中 HO-1mRNA 表达均降低,MCP-1 mRNA 表达均增高(P<0.05~0.01),差异有统计学意义,且心肌超微结构损伤加重。结论:促红素预处理可能通过增强 HO-1表达并降低 MCP-1表达,改善心肌超微结构的损伤,对大鼠心肌缺血再灌注损伤产生保护作用。 Objective:To explore the protective effect and possible mechanism of the pretreatment with erythropoietin in rats with the myocardial ischemia-reperfusion(IR) injury. Methods:A total of 40 male Sprague-Dawley rats were randomly divided into 5 groups:sham operation group (F group), operation group( O group ), erythropoietin group (E group ), zinc protoporphyrin group (Z group ), and erythropoietin + zinc protoporphyrin group( ZE group). There were 8 rats in each group. The rat model of myocardial IR injury was reproduced by the ligation of left anterior descending coronary artery(LAD) for 45 minutes followed by 180 minutes of reperfusion. The LAD of F group was not clamped. The E group was pretreated with the intraperitoneal injection of erythropoietin(4 000 U/Kg)24hours before IR,and the Z group with the intraperitoneal injection of zinc protoporphyrin (20 μmol/kg)12 hours before IR, and the ZE group with erythropoietin(4 000 U/Kg)24 hours before IR combined with zinc protoporphyrin( 20 μmol/kg)12 hours before IR. The expression of MCP-1 and HO-1 protein and mRNA in left ventricle was detected by immunohistochemistry and RT-PCR. The changes of myocardial ultrastructurc were observed with transmission electronmicroscopy(TEM). Results:Compared with F group, the expression of MCP-1 and HO-1 mRNA increased significantly in other groups (P 〈 0. 01 ) ;compared with O group ,erythropoietin could significantly increase the expression of HO-1 and decrease the expression of MCP-1 induced by IR(P 〈 0. 05 - 0. 01 ), and markedly decrease the injury of the myocardial uhrastructure caused by IR. The protective effects of erythropoietin were prevented by zinc protoporphyrin ( P 〉 0.05 ). Compared with E group, the expression of HO-1 decreased and the expression of MCP-1 increased significantly in Z and ZE groups ( P 〈 0. 05 - 0. 01 ) , and the injury of myocardial ultrastructure was aggravated. Conclusion: The pretreatment of erythropoietin could protect cardiomyocyte against ischemia-reperfusion injury, probably through up-regulating HO-1 expression and de-regulating MCP-1 expression.
出处 《中国循环杂志》 CSCD 北大核心 2008年第4期306-309,共4页 Chinese Circulation Journal
关键词 促红细胞生成素 缺血再灌注损伤 单核细胞趋化蛋白-1 血红素加氧酶-1 心肌超微结构 Erythropoietin Ischemia-reperfusion injury Monocyte chemoattractant protein-1 Heme oxygenase-1 Myocardial ultrastructure
  • 相关文献

参考文献11

  • 1秦川,肖颖彬.促红细胞生成素心肌保护作用的研究进展[J].中国胸心血管外科临床杂志,2006,13(2):113-116. 被引量:4
  • 2Calo LA, Stanic L, Davis PA, et al. Effect of epoetin on HO-1 mRNA level and plasma antioxidants in hemodialysis patients. Int J Clin Pharmacol Ther,2003,41 : 187-192.
  • 3Masini E,Vannacci A, Marzocca C, et al. Heme Oxygenase-1 and the ischemia-Reperfusion injury in the rat heart. Experimental Biology and Medicine, 2003,228 : 546 -549.
  • 4Kakio T, Matsumori A,Ono K, et al. Roles and relationship of macrophages and monocyte chemotactic and activating factor/monocyte chemoattractant protein-I in the ischemic and reperfused rat heart. Lab Invest ,2000,80 : 1127-1136.
  • 5Kupiec-Weglinski JW, Busuttil RW. Ischemia and reperfusion injury in liver transplantation. Transplant Proc ,2005 ,37 (4) : 1653-1656.
  • 6Murali NS,Aekerman AW, Croatt AJ,et al. Renal upregulation of HO- 1 reduces albumin-driven MCP-1 production:implications for chronic kidney disease. Am J Physiol Renal Physiol, 2007,292 ( 2 ) : 837-844.
  • 7Minamino T, Christou II, Hsieh C, et al. Targeted expression of heine oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc Natl Acad Sci USA,2001,98 (15) :8798-8803.
  • 8Zhou LM, Azfer A, Niu JL, et al. Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocytc apoptosis and ventricular dysfunction. Circ Rcs,2006,98(9) :1177-1185.
  • 9Pawlak K, Pawlak D, Mysliwiec M. Long-term erythropoietin therapy decreases CC-chemokine levels and intima-media thickness in hemodialyzed patients. Am J Nephrol,2006,26( 5 ) :497-502.
  • 10Chong ZZ, Kang JQ, Maiese K. Erythropoietin is a novel vascular protectant through activation of aktl and mitochundrial modulation of cysteine proteases. Circulation ,2002,106 ( 23 ) :2973-2979.

二级参考文献24

  • 1Jaquet K,Krause K,Tawakol-Khodai M,et al.Erythropoietin and VEGF exhibit equal angiogenic potential.Microvasc Res,2002,64(2):326-333.
  • 2Juul SE,Yachnis AT,Christensen RD.Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus.Early Hum Dev,1998,52(3):235-249.
  • 3Tramontano AF,Muniyappa R,Black AD,et al.Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway.Biochem Biophys Res Commun,2003,308(4):990-994.
  • 4Cai Z,Manalo DJ,Wei G,et al.Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury.Circulation,2003,108 (1):79-85.
  • 5Calvillo L,Latini R,Kajstura J,et al.Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling.Proc Natl Acad Sci USA,2003,100(8):4802-4806.
  • 6Parsa C J,Matsumoto A,Kim J,et al.A novel protective effect of erythropoietin in the infarcted heart.J Clin Invest,2003,112(7):999-1007.
  • 7Moon C,Krawczyk M,Ahn D,et al.Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats.Proc Natl Acad Sci USA,2003,100(20):11612-11617.
  • 8Xu B,Dong GH,Liu H,et al.Recombinant human erythropoietin pretreatment attenuates myocardial infarct size:a possible mechanism involves heat shock Protein 70 and attenuation of nuclear factor-kappaB.Ann Clin Lab Sci,2005,35(2):161-168.
  • 9Lipsic E,van der Meer P,Henning RH,et al.Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion.J Cardiovasc Pharmacol,2004,44 (4):473-479.
  • 10Ghezzi P,Brines M.Erythropoietin as an antiapoptotic,tissue-protective cytokine.Cell Death Differ,2004,11(Suppl 1):S37-S44.

共引文献3

同被引文献96

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部